| Schedule of Earnings Per Share Basic Aand Diluted |
The following table sets forth the computation of basic and diluted net loss per share of common stock for the three months ended March 31, 2022, and 2021 (in thousands, except for share and per share data):
|
|
|
|
|
|
|
|
|
| |
|
Three Months Ended March 31, |
|
| |
|
|
|
|
|
|
|
|
$ |
(10,470 |
) |
|
$ |
(7,787 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average Class A Common Stock outstanding |
|
|
53,691,948 |
|
|
|
21,847,581 |
|
Loss per share for Class A Common Stock |
|
|
|
|
|
|
|
|
|
|
$ |
(0.20 |
) |
|
$ |
(0.36 |
) |
|
|
$ |
(0.20 |
) |
|
$ |
(0.36 |
) |
|
| Schedule of Antidilutive Securities Excluded From Computation of Earnings |
The Company excluded the following weighted average potential common shares from the computation of diluted net loss per share for the three months ended March 31, 2022 and March 31, 2021:
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
Convertible Series C-1 Preferred Stock (2) |
|
|
— |
|
|
|
23,218,418 |
|
Convertible Series C Preferred Stock (2) |
|
|
— |
|
|
|
54,478,261 |
|
Common Stock Warrants (2)(3) |
|
|
14,959,214 |
|
|
|
1,890,522 |
|
|
|
|
10,114,849 |
|
|
|
13,185,484 |
|
Restricted Stock Units(1) |
|
|
9,077,015 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
34,151,078 |
|
|
|
92,772,685 |
|
|
|
|
|
|
|
|
|
|
| (1) |
The number of outstanding shares as of March 31, 2022 includes 952,127 shares of vested RSUs because the Company has not met all the condition to issue the underlying common stocks as of March 31, 2022. Common stock underlying the vested RSUs will not be issued until the related registration statement becomes effective. |
| (2) |
The number of outstanding shares as of March 31, 2021 have been retrospectively adjusted to reflect the Exchange Ratio. |
| (3) |
The number of outstanding shares as of March 31, 2022 and March 31, 2021 does not include 1,608,359 shares of Unvested Customer Warrants. |
|